103 related articles for article (PubMed ID: 6428200)
1. [Clinical effect of UFT on urogenital tumors].
Masuda F; Arai Y; Tashiro K; Machida T
Hinyokika Kiyo; 1984 Jan; 30(1):81-5. PubMed ID: 6428200
[TBL] [Abstract][Full Text] [Related]
2. [Clinical effect of UFT on bladder cancer].
Asahi T; Matsumura Y; Ozaki Y; Yoshimoto J; Kaneshige T; Kumon H; Tsushima T; Ohmori H
Gan To Kagaku Ryoho; 1982 Mar; 9(3):503-7. PubMed ID: 6820901
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
Nakagami Y; Lin TT; Ito H; Hirasawa S; Tannawa K; Fujioka Y; Ogawa H; Tanaka K; Yamada N; Ishii Y
Hinyokika Kiyo; 1987 Oct; 33(10):1728-32. PubMed ID: 3128071
[TBL] [Abstract][Full Text] [Related]
4. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
[TBL] [Abstract][Full Text] [Related]
5. [Phase II study of UFT for malignant tumors of urinary organs].
Shida K; Yamanaka H; Ito Y; Shimazaki J; Isaka S; Yokokawa M; Fukui I; Kawai H; Akimoto M; Yoshida K
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1307-14. PubMed ID: 6428325
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effect of UFT on prostatic cancer].
Naito K; Hisazumi H; Misaki T; Shimada K; Miyazaki K; Kosaka S; Miyagi T
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1440-4. PubMed ID: 3925886
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study of UFT in renal cell carcinoma].
Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):325-30. PubMed ID: 3918508
[TBL] [Abstract][Full Text] [Related]
9. [Effective cases of advanced endometrial and recurrent ovarian cancers treated with oral administration of UFT].
Akiyama J; Sagara Y; Takeda Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3):521-6. PubMed ID: 6422860
[TBL] [Abstract][Full Text] [Related]
10. [Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].
Niijima T; Aso Y; Akaza H; Kameyama S; Koiso K; Kawabe K; Kawamura T; Isurugi K; Yokoyama M; Shoji F
Gan To Kagaku Ryoho; 1988 Jan; 15(1):109-14. PubMed ID: 3122664
[TBL] [Abstract][Full Text] [Related]
11. [Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
Yoshida K; Nakame Y; Horiuchi S; Kaneoya F; Kuroda T; Tanoiri A; Koizumi M; Takahashi M; Negishi T; Saitoh H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1083-5. PubMed ID: 3083786
[No Abstract] [Full Text] [Related]
12. [UFT].
TakuchiT
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1692-6. PubMed ID: 6433802
[No Abstract] [Full Text] [Related]
13. [A phase II study of UFT in non-small cell lung cancer].
Shimizu E; Kimura K; Sone S; Inoue I; Nakamura Y; Noda Y; Hojo F; Yagi M; Nakanishi S; Yamasaki K
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2970-3. PubMed ID: 3021068
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic effect of UFT on the recurrence of bladder cancer].
Naito K; Hisazumi H; Saka A; Nakamura T; Kanda S; Mikawa I; Ejiri S; Miyagi T; Katsumi T; Kitagawa K
Hinyokika Kiyo; 1990 Apr; 36(4):487-94. PubMed ID: 2116083
[TBL] [Abstract][Full Text] [Related]
15. [Case report of a complete regression of para-aortic lymph node metastasis from bladder cancer by oral administration of UFT].
Nakano E; Iwasaki A; Seguchi T; Sugao H; Yoshioka T; Tada Y; Matsuda M; Sonoda T
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):415-7. PubMed ID: 2494950
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and toxicity of lower dose UFT without leucovorin in metastatic gastric cancer patients.
Somali I; Meydan N; Tarhan MO; Oztop I; Alacacioglu A; Yilmaz U
J BUON; 2009; 14(3):429-33. PubMed ID: 19810134
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of UFT in recurrent or advanced cancer].
Kunitomo K; Kuwashima T; Korematsu H; Tamura T; Yoshikawa H; Toyosaki M; Komi N
Gan To Kagaku Ryoho; 1982 Jan; 9(1):72-8. PubMed ID: 6820878
[TBL] [Abstract][Full Text] [Related]
18. [Successful inhibition of bladder tumor recurrence by oral administration of UFT].
Nakamoto T; Igawa M; Usui T
Gan To Kagaku Ryoho; 1994 Apr; 21(5):697-9. PubMed ID: 8154896
[No Abstract] [Full Text] [Related]
19. Combination chemotherapy with Tegafur. Uracil (UFT), etoposide, adriamycin and cisplatinum (UFT-EAP) for advanced gastric cancer.
Hayakawa M; Morise K; Chin K; Sugihara M; Morooka Y; Maeda H; Hattori T; Saito H
Jpn J Clin Oncol; 1994 Oct; 24(5):282-8. PubMed ID: 7967107
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
Ikeda M; Okusaka T; Ueno H; Morizane C; Furuse J; Ishii H
Jpn J Clin Oncol; 2005 Aug; 35(8):439-43. PubMed ID: 16024530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
